Back to Search Start Over

Validation externe de l'essai VESPER comparant l'efficacité des protocoles de chimiothérapie néoadjuvante par méthotrexate, vinblastine, doxorubicine et cisplatine dose dense (dd-MVAC) vs gemcitabine et cisplatine (GC) chez les...

Authors :
Grobet-Jeandin, E.
Thibault, C.
Borz, M.B.
Vordos, D.
Gabriel, P.E.
De Olivera, A.
Arber, T.
Colombel, M.
Chatain, V.
Mauger De Varennes, A.
Ghenassia, M.
Peyrottes, A.
Beniac, P.
Léon, P.
Taha, F.
Szostek, A.
Calleris, G.
Rouprêt, M.
Roumiguié, M.
Seisen, T.
Source :
Proges en Urologie; 2024 Supplement, Vol. 34, pS61-S61, 1p
Publication Year :
2024

Abstract

<i>Copyright of Proges en Urologie is the property of Elsevier B.V. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.</i> (Copyright applies to all Abstracts.)

Details

Language :
French
ISSN :
1761676X
Volume :
34
Database :
Supplemental Index
Journal :
Proges en Urologie
Publication Type :
Academic Journal
Accession number :
180678812
Full Text :
https://doi.org/10.1016/j.fpurol.2024.07.087